Navigation Links
Stryker Launches VersiTomic G-Lok™
Date:7/7/2011

SAN DIEGO, July 7, 2011 /PRNewswire/ -- Stryker Joint Preservation, a business unit of Stryker's Orthopaedics group, today announced at the 2011 American Orthopaedic Society for Sports Medicine its new G-Lok implant has joined its comprehensive VersiTomic portfolio for ACL/PCL reconstruction.

Built upon the same versatile, anatomic, and reliable advanced technology as products currently in the VersiTomic portfolio, the VersiTomic G-Lok is designed to provide suspension fixation of soft tissue to bone during orthopaedic reconstruction procedures.  

The G-Lok's unique rod design creates a spring-like action which allows the G-Lok to automatically deploy on the cortical surface. G-Lok's loop material is made from the latest technology in high performance medical-grade fiber from Dyneema Purity, available in multiple loop sizes, and is designed to increase creep resistance and enhance strength(1). In addition, G-Lok XL is available to provide an additional 5mm in length and 1mm in width to the G-Lok.

"Our VersiTomic platform  is designed to provide surgeons with the flexibility and versatility they need to create a more anatomic ACL or PCL reconstruction while allowing them to customize their technique to the patient," said Matt Moreau, Vice President & General Manager, Stryker Joint Preservation.

G-Lok joins Stryker's VersiTomic Flexible Reaming System whose puzzle piece technology allows for anatomically placed tunnels without the need to hyperflex the knee, and its Biosteon Biocomposite Interference Screws, with over nine years of clinical use, for a comprehensive solution to ACL/PCL reconstruction.

To see a demonstration of these products, please visit Stryker at booth #503 at AOSSM.

About Stryker OrthopaedicsStryker Orthopaedics is a division of the Stryker Corporation, one of the world's leading medical technology companies. Stryker Orthopaedics offers an extensive orthopaedic product portfolio including hip, knee and upper extremity reconstructive devices, bone cement, trauma implants, bone substitutes, joint preservation products and spine systems. For more information about Stryker Orthopaedics, visit: http://www.stryker.com/en-us/products/Orthopaedics/index.htm

About StrykerStryker is one of the world's leading medical technology companies and is dedicated to helping healthcare professionals perform their jobs more efficiently while enhancing patient care. The Company offers a diverse array of innovative medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products to help people lead more active and more satisfying lives. For more information about Stryker, please visit www.stryker.com.

(1) DSM0972- Product Leaflet Dyneema Purity® UGContact:Jeanine GuilfoyleStryker Orthopaedics201-831-6277jeanine.guilfoyle@stryker.com  
'/>"/>

SOURCE Stryker Orthopaedics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Stryker Orthopaedics Launches Its First iPad™ Apps for Surgeons, Available Through Apples App Store(SM)
2. Stryker Features Tissue-Preservation Hip Arthroscopy Platform, Sponsors Surgeon Education Events at the AAOS Annual Meeting
3. Fred Funk Becomes Spokesperson for Stryker Orthopaedics
4. Stryker Receives FDA 510(k) Clearance to Market Modular Dual Mobility Acetabular (Hip) System
5. Stryker Declares a $0.18 Per Share Quarterly Dividend
6. Stryker Completes Sale of OP-1 for use in Orthopaedic Bone Applications to Olympus
7. Stryker Reports 9% Sales Growth, 13% Adjusted Net Earnings Growth for Quarter Ended December 31, 2010
8. Stryker Corporation Named One of FORTUNE Magazines 100 Best Companies to Work For
9. TriMed, Inc. Announces Licensing Agreement with Stryker
10. Stryker Increases Expected 2010 Results and Provides 2011 Outlook
11. Stryker Completes Acquisition of the Neurovascular Division of Boston Scientific
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... Feb. 22, 2017 Summary Provides ... partnering deals and agreements entered into by the worlds ... http://www.reportlinker.com/p03605668-summary/view-report.html Description The Global Non-Small Cell Lung ... understanding and access to partnering deals and agreements entered ... - Trends in partnering deals - Top deals ...
(Date:2/22/2017)... , February 22, 2017 Arthroscopy Devices Market Report, published ... in 2015 and is projected to reach $5,334 million by 2022, growing at a ... of the total market in 2015. Continue Reading ... ... ...
(Date:2/22/2017)... MERIDEN, Conn. , Feb. 22, 2017   ... and maker of Flublok® Influenza Vaccine , announced ... The Partnership for Influenza Vaccine Introduction (PIVI) and the ... the devastating impacts of the flu.  The doses of ... of Mongolia for health care ...
Breaking Medicine Technology:
(Date:2/22/2017)... , ... February 22, 2017 , ... Doctors on Liens ... of esteemed ophthalmologist, Dr. Steven H. Rauchman, practicing at North Valley Eye Medical ... accidents, product liability, premise liability and other personal injury cases. These injuries have ...
(Date:2/22/2017)... ... February 22, 2017 , ... The first-ever National ... organizations, advocates, and individuals join together to increase recognition about the risks of ... lives. , “Today we mark a nationwide movement to raise awareness about a ...
(Date:2/22/2017)... ... February 22, 2017 , ... Bellus ... the latest innovation in the delivery of Platelet Rich Plasma (PRP). PRP systems ... pain management, to accelerate tissue synthesis and provide a faster and more efficient ...
(Date:2/22/2017)... , ... February 22, 2017 , ... The SeniorCare Investor ... 2017 Forecast —on Thursday, February 23, 2017, at 1:00 PM ET. A recording of ... part of the Interactive Webinar Series. , If you want to find out what ...
(Date:2/22/2017)... Marlton, NJ (PRWEB) , ... February 22, 2017 ... ... has served military veterans who suffer from combat-related PTSD. , Established in 1977, ... During the Vietnam-era, the challenges of military returning to civilian life were evident ...
Breaking Medicine News(10 mins):